| P50 | author | Tsuyoshi Yokoi | Q61658900 |
| P2093 | author name string | Kei Takahashi | |
| | Tatsuki Fukami | |
| | Miki Nakajima | |
| | Yasuyuki Toyoda | |
| | Yuki Oda | |
| P2860 | cites work | Human CYP2E1 is regulated by miR-378. | Q43234181 |
| | Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions | Q43577472 |
| | Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation | Q44942814 |
| | Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. | Q52595110 |
| | Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. | Q54564037 |
| | Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions | Q68755416 |
| | Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner | Q84719480 |
| | Potential role of miR-9 and miR-223 in recurrent ovarian cancer | Q21245724 |
| | Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 |
| | Most mammalian mRNAs are conserved targets of microRNAs | Q24655061 |
| | The functions of animal microRNAs | Q27860621 |
| | MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | MicroRNA expression profiles classify human cancers | Q28032481 |
| | The many roles of cytochrome b5 | Q28206247 |
| | Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants | Q28260351 |
| | Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation | Q28585425 |
| | THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE | Q29547810 |
| | A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 |
| | Myoglobin: cytochrome b5 interactions and the kinetic mechanism of metmyoglobin reductase | Q34051506 |
| | E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response | Q34134744 |
| | Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 |
| | Congenital methemoglobinemia with a deficiency of cytochrome b5. | Q34196518 |
| | Human CYP1B1 is regulated by estradiol via estrogen receptor | Q34318651 |
| | An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. | Q34625798 |
| | MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 |
| | microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification | Q34922055 |
| | Lost in translation: an assessment and perspective for computational microRNA target identification | Q35005629 |
| | Rate-limiting steps in cytochrome P450 catalysis | Q35009284 |
| | The roles of cytochrome b5 in cytochrome P450 reactions | Q35025216 |
| | MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. | Q37874753 |
| | Cytochrome b5: novel roles in steroidogenesis | Q38066318 |
| | Regulation of cytochrome b5 gene transcription by Sp3, GATA-6, and steroidogenic factor 1 in human adrenal NCI-H295A cells | Q38327992 |
| | Immunological similarity between NADH-cytochrome b5 reductase of erythrocytes and liver microsomes | Q39075844 |
| | An in vitro drug-induced hepatotoxicity screening system using CYP3A4-expressing and gamma-glutamylcysteine synthetase knockdown cells. | Q39767325 |
| | Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b | Q39830496 |
| | MicroRNA regulates the expression of human cytochrome P450 1B1. | Q40230494 |
| | Establishment of the transformants expressing human cytochrome P450 subtypes in HepG2, and their applications on drug metabolism and toxicology | Q40802962 |
| | Defining the in Vivo Role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. | Q41824446 |
| | Deletion of microsomal cytochrome b5 profoundly affects hepatic and extrahepatic drug metabolism | Q43079448 |
| P433 | issue | 3 | |
| P304 | page(s) | 780-794 | |
| P577 | publication date | 2014-03-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Regulation of cytochrome b5 expression by miR-223 in human liver: effects on cytochrome P450 activities | |
| P478 | volume | 31 | |